RemedEase Inc. Raises First Round of Funding
Posted: 08-07-2008 : DURHAM, N.C.
Durham, NC - RemedEase Inc. a life science company with patented advanced technology to stop nosebleeds announced that it has closed on its first round of financing. RemedEase will use the funds to support product development, begin the FDA 510K approval process and expand marketing initiatives.
The company’s patented device, NOseBLEED, stops nosebleeds quickly, easily, comfortably and very conveniently and does not interrupt normal breathing or activity. NOseBLEED will be a significant advancement in the care of nosebleeds, as it does not require an individual to put anything in the nose. “Nosebleeds are messy, embarrassing nuisances if they happen at home, but are even more troubling when they occur in public,” said RemedEase CEO Amy Rix. “Many people have underlying medical conditions that can cause sudden bleeding NOseBLEEDS technology will serve the needs of a wide spectrum of patients including athletes, children seniors and those suffering side effects of diseases and drugs.” RemedEase board member James Buck, vice president of marketing and business development at Innerpulse, adds that, “With an astounding 445 million episodes of recurring nosebleeds in the U.S. alone in 2007, there is clearly a large market opportunity for RemedEase. This is a fairly unmet market, and the adoption for RemedEase could mimic that of a product such as Breathe Right which has evolved into a well known brand.”
CEO Amy Rix, founder and inventor of the RemedEase technology has spent the past 15 years in the professional medical field as an EMT, CNA and with UNC Medical School as a Research Associate. Amy is the winner of the 2005 Carolina Challenge Business Plan Competition and winner of the 2005 Coach’s Progress Award from the Launching the Company Program at UNC Kenan-Flagler business school. Randy Myer, chairman of the RemedEase board of directors and Entrepreneurship Professor of the Practice at UNC Kenan-Flager stated, “Her selection was endorsed by our board of directors and investors, and we are confident that she is the ideal person to lead the Company into its next chapter.” RemedEase has attracted an outstanding group of angel investors with extensive experience in both established and start up environments.
Grace W. Ueng, founder and CEO of Savvy Marketing Group, who serves on the RemedEase board stated, “It has been a privilege to help incubate and commercialize talent out of UNC Chapel Hill, We are thrilled to close on the first round of funding for RemedEase to take their innovation to the next phase of growth.”
About RemedEase
Founded in 2005, RemedEase is a privately held early-stage company headquartered in Durham, North Carolina. RemedEase is developing an innovative, disposable product to remedy nosebleeds quickly, easily, comfortably and conveniently.
Contact: Amy Rix
RemedEase Inc.
(919) 510-5123
(919 698-7681 (cell)
arix@remedeaseinc.com
|
